England captain Harry Kane has taken part in a £1.4m investment into a Chester-based health food brand.
The Tottenham striker has joined a number of "high profile investors" in backing Bio&Me
The investment round was over subscribed and closed within 72 hours. The company will use the funds to fuel growth including "significant innovation in the cereal aisle and beyond".
READ MORE: Boohoo eyes full-year profits of £125m as sales surge
Last year, Bio&Me trebled its sales to £3m and has said it is on track to treble again in 2022.
The company's products are stocked in over 1,400 stores nationwide in Sainsbury’s, the Co-Op, Waitrose, via Ocado.
Dr Megan Rossi, Bio&Me co-founder, said: "We’re delighted that Harry is coming onboard as one of our investors.
"As a dietitian and a scientist, it’s always been my mission to close the gap on great tasting food that also truly delivers on its health claims.
"I believe that’s what makes Bio&Me such an exciting proposition for consumers and investors alike."
Harry Kane added: "As a professional footballer, good nutrition and diet are very important to me.
"Bio&Me’s growth trajectory has been phenomenal and I’m thrilled to be playing a part in the brand’s next chapter."
Bio&Me co-founder and CEO Jon Walsh said: "Bio&Me is clearly striking a chord with consumers. The brand’s success is also down to some key supermarket buyers believing in us and supporting us over the last 12 months.
"Moving forward, we aim to make the brand accessible to even more consumers across a variety of formats, as well as looking further afield and launching products in different Food & Beverage categories."
The funding round was guided by Bio&Me’s lead investor and serial FMCG entrepreneur, Giles Brook.
He added: "Consumer health and wellness start from within and I firmly believe gut health will eclipse protein as the next global macro consumer trend.
"Bio&Me’s meteoric rise has been driven by great tasting, truly differentiated prebiotic goodness with Megan and her team bringing authenticity and validation.
"The fact we were over subscribed and closed the investment round within 72 hours is testament to the belief in the category and Bio&Me. Exciting times ahead."
